Lack of reliability of nanotechnology in the of free plasma DNA in samples of patients with prostate cancer

2013 
Background Several studies seek biological markers that give diagnostic and degree of tumor development. The aim of this study was to validate the determination of plasma DNA using nanotechnology (Nanovue™-NV) in samples of 80 patients with prostate cancer.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    22
    References
    1
    Citations
    NaN
    KQI
    []